Trial ID: | L1407 |
Source ID: | NCT06389617
|
Associated Drug: |
Supraclavicular Block With 20mls Of Ropivacaine 0.5% And Intravenous Administered Dexamethasone
|
Title: |
Different Doses of Intravenous Administered Dexamethasone Effecting Brachial Plexus Supraclavicular Block
|
Acronym: |
|
Status: |
NOT_YET_RECRUITING
|
Study Results: |
NO
|
Results: |
|
Conditions: |
End Stage Renal Failure
|
Interventions: |
DRUG: supraclavicular block with 20mls of Ropivacaine 0.5% and Intravenous administered dexamethasone
|
Outcome Measures: |
Primary: To compare the difference of onset time between sensory and motor block of supraclavicular block between ropivacaine with IV dexamethasone 4mg and ropivacaine with IV dexamethasone 8mg, 2 days|To compare the difference in duration of analgesia between supraclavicular block with ropivacaine and IV dexamethasone 4mg with ropivacaine and IV dexamethasone 8mg, 2 days | Secondary: To compare the duration difference of the return of motor block between supraclavicular block using ropivacaine with IV dexamethasone 4mg and ropivacaine with IV dexamethasone 8mg, 2 days
|
Sponsor/Collaborators: |
Sponsor: Hospital Universiti Sains Malaysia
|
Gender: |
ALL
|
Age: |
ADULT, OLDER_ADULT
|
Phases: |
|
Enrollment: |
50
|
Study Type: |
INTERVENTIONAL
|
Study Designs: |
Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: DOUBLE (PARTICIPANT, CARE_PROVIDER)|Primary Purpose: SUPPORTIVE_CARE
|
Start Date: |
2024-05-01
|
Completion Date: |
2024-12-30
|
Results First Posted: |
|
Last Update Posted: |
2024-04-29
|
Locations: |
|
URL: |
https://clinicaltrials.gov/show/NCT06389617
|